The University of Warwick is being given more than £5 million to improve the delivery of healthcare to some of the world’s poorest people.
News
Gov’t unveils £86m package to support SMEs
Health minister Lord O’Shaughnessy has unveiled a new package of support worth up to £86 million to help innovative UK businesses develop medical breakthroughs that are then used across the NHS.
Gilead’s new HIV therapy under EU review
European regulators are now reviewing Gilead’s fixed-dose combination of bictegravir (BIC), emtricitabine and tenofovir alafenamide as a treatment for HIV-1 infection.
Green light for Janssen Tremfya in the US
US regulators have issued a green light for Janssen Biotech’s new biologic Tremfya to treat moderate to severe plaque psoriasis.
Dementia consortium launches brain imaging study
Dementia researchers will be able to tap into investment of £1.9 million for work on identifying the earliest brain changes linked with conditions such as Alzheimer’s disease.
NICE backs Humira, Enbrel and Stelara for plaque psoriasis in children
AbbVie’s Humira, Pfizer’s Enbrel, and Janssen’s Stelara are being recommended as options for treating plaque psoriasis in children and young people on the NHS.
Amgen’s Blincyto wins full US approval
Amgen’s Blincyto has been issued a full approval in the US as a treatment for adults and children with relapsed or refractory B-cell precursor acute lymphoblastic leukaemia (ALL).
EU & UK pharma leaders write to Brexit negotiators
In an unprecedented move, eight leaders from associations representing the entire EU and UK pharmaceutical sector have written a joint letter to chief Brexit negotiators Michel Barnier and David Davis requesting that ongoing cooperation between the two territories for medicines be a negotiating priority.
FDA panel backs Novartis’ CAR-T therapy CTL019
Novartis’ CTL019 has taken a giant leap towards the finishing line in the race to get the first cancer killing CAR-T cell therapy on the market having won the support of an FDA advisory panel.
Hospitals get £21m to ramp up cyber security
Major trauma centres across England are to get access to a new fund of £21 million to tighten up their cyber security, the Department of Health has announced.
First UK patient enrolled in peanut allergy trial
Children and adolescents in the UK with peanut allergy are among the first to enrol in a Europe-wide study investigating a new oral immunotherapy for the condition.
More managers, better NHS Trust performance, finds report
Increasing the number of managers employed at NHS Trusts could help improve Trust performance, suggest findings from an analysis undertaken by researchers at Warwick Business School and the Universities of Bristol and Leeds.
MenB vaccine shows promise against gonorrhoea
Researchers in New Zealand have found that teenagers given a meningitis B vaccine were significantly less likely to contract gonorrhoea, marking the first time a vaccine has shown any protection against the sexually transmitted infection (STI).
Councils cut planned spend on public health by £85m, analysis finds
Central government cuts have forced councils in England to cut their planned spend on vital public health services by £85 million, according to new analysis by The King’s Fund.
Thinking of making the move into marketing?
This is the opportunity you’ve been waiting for!
The PharmaTimes Marketer of the Year Competition is open for entry, and the great news is, you don’t have to be in a marketing role to take part.
